143 related articles for article (PubMed ID: 38485431)
1. Point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-resource settings (WANTAIM): a pragmatic cluster randomised crossover trial in Papua New Guinea.
Riddell MA; Vallely LM; Mengi A; Badman SG; Low N; Wand H; Bolnga JW; Babona D; Mola GDL; Wiseman V; Kelly-Hanku A; Homer CSE; Morgan C; Luchters S; Whiley DM; Robinson LJ; Au L; Pukai-Gani I; Laman M; Kariwiga G; Toliman PJ; Batura N; Tabrizi SN; Rogerson SJ; Garland SM; Guy RJ; Peeling RW; Pomat WS; Kaldor JM; Vallely AJB;
Lancet Glob Health; 2024 Apr; 12(4):e641-e651. PubMed ID: 38485431
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care testing and treatment of sexually transmitted infections to improve birth outcomes in high-burden, low-income settings: Study protocol for a cluster randomized crossover trial (the WANTAIM Trial, Papua New Guinea).
Vallely AJ; Pomat WS; Homer C; Guy R; Luchters S; Mola GDL; Kariwiga G; Vallely LM; Wiseman V; Morgan C; Wand H; Rogerson SJ; Tabrizi SN; Whiley DM; Low N; Peeling R; Siba P; Riddell M; Laman M; Bolnga J; Robinson LJ; Morewaya J; Badman SG; Batura N; Kelly-Hanku A; Toliman PJ; Peter W; Babona D; Peach E; Garland SM; Kaldor JM
Wellcome Open Res; 2019; 4():53. PubMed ID: 32030356
[No Abstract] [Full Text] [Related]
3. A novel point-of-care testing strategy for sexually transmitted infections among pregnant women in high-burden settings: results of a feasibility study in Papua New Guinea.
Badman SG; Vallely LM; Toliman P; Kariwiga G; Lote B; Pomat W; Holmer C; Guy R; Luchters S; Morgan C; Garland SM; Tabrizi S; Whiley D; Rogerson SJ; Mola G; Wand H; Donovan B; Causer L; Kaldor J; Vallely A
BMC Infect Dis; 2016 Jun; 16():250. PubMed ID: 27268218
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial.
Guy RJ; Ward J; Causer LM; Natoli L; Badman SG; Tangey A; Hengel B; Wand H; Whiley D; Tabrizi SN; Shephard M; Fairley CK; Donovan B; Anderson DA; Regan DG; Maher L; Kaldor JM
Lancet Infect Dis; 2018 Oct; 18(10):1117-1126. PubMed ID: 30303108
[TBL] [Abstract][Full Text] [Related]
6. Point-of-care testing and treatment of sexually transmitted and genital infections during pregnancy in Papua New Guinea (WANTAIM trial): protocol for an economic evaluation alongside a cluster-randomised trial.
Batura N; Saweri OP; Vallely A; Pomat W; Homer C; Guy R; Luchters S; Mola G; Vallely LM; Morgan C; Kariwiga G; Wand H; Rogerson S; Tabrizi SN; Whiley DM; Low N; Peeling RW; Siba PM; Riddell M; Laman M; Bolnga J; Robinson LJ; Morewaya J; Badman S; Kelly-Hanku A; Toliman PJ; Peter W; Peach E; Garland S; Kaldor J; Wiseman V
BMJ Open; 2021 Aug; 11(8):e046308. PubMed ID: 34385236
[TBL] [Abstract][Full Text] [Related]
7. Midwifery continuity of care versus standard maternity care for women at increased risk of preterm birth: A hybrid implementation-effectiveness, randomised controlled pilot trial in the UK.
Fernandez Turienzo C; Bick D; Briley AL; Bollard M; Coxon K; Cross P; Silverio SA; Singh C; Seed PT; Tribe RM; Shennan AH; Sandall J;
PLoS Med; 2020 Oct; 17(10):e1003350. PubMed ID: 33022010
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the diagnosis and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae in pregnant women to prevent adverse neonatal consequences in Gaborone, Botswana: protocol for the Maduo study.
Wynn A; Mussa A; Ryan R; Hansman E; Simon S; Bame B; Moreri-Ntshabele B; Ramogola-Masire D; Klausner JD; Morroni C
BMC Infect Dis; 2022 Mar; 22(1):229. PubMed ID: 35255814
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factors of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and other sexually transmissible infections among women attending antenatal clinics in three provinces in Papua New Guinea: a cross-sectional survey.
Vallely LM; Toliman P; Ryan C; Rai G; Wapling J; Tomado C; Huliafi S; Munnull G; Rarau P; Phuanukoonnon S; Wand H; Siba P; Mola GDL; Kaldor JM; Vallely AJ
Sex Health; 2016 Oct; 13(5):420-427. PubMed ID: 28636866
[TBL] [Abstract][Full Text] [Related]
10. Performance of syndromic management for the detection and treatment of genital
Vallely LM; Toliman P; Ryan C; Rai G; Wapling J; Gabuzzi J; Allen J; Opa C; Munnull G; Kaima P; Kombuk B; Kumbia A; Kombati Z; Law G; Kelly-Hanku A; Wand H; Siba PM; Mola GDL; Kaldor JM; Vallely AJ
BMJ Open; 2017 Dec; 7(12):e018630. PubMed ID: 29288183
[TBL] [Abstract][Full Text] [Related]
11. Association between visual inspection of the cervix with acetic acid examination and high-risk human papillomavirus infection, Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in Papua New Guinea.
Vallely AJ; Toliman PJ; Ryan C; Rai G; Wapling J; Gabuzzi J; Kumbia A; Kombuk B; Kombati Z; Vallely LM; Kelly-Hanku A; Wand H; Tabrizi SN; Mola GDL; Kaldor JM
Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):576-581. PubMed ID: 29380356
[TBL] [Abstract][Full Text] [Related]
12. Sexually transmitted infection screening to prevent adverse birth and newborn outcomes: study protocol for a randomized-controlled hybrid-effectiveness trial.
Medina-Marino A; Cleary S; Muzny CA; Taylor C; Tamhane A; Ngwepe P; Bezuidenhout C; Facente SN; Mlisana K; Peters RPH; Klausner JD
Trials; 2022 May; 23(1):441. PubMed ID: 35610666
[TBL] [Abstract][Full Text] [Related]
13. Targeted point-of-care testing compared with syndromic management of urogenital infections in women (WISH): a cross-sectional screening and diagnostic accuracy study.
Verwijs MC; Agaba SK; Sumanyi JC; Umulisa MM; Mwambarangwe L; Musengamana V; Uwineza M; Cuylaerts V; Crucitti T; Jespers V; van de Wijgert JHHM
Lancet Infect Dis; 2019 Jun; 19(6):658-669. PubMed ID: 31031172
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant women in Papua New Guinea.
Wangnapi RA; Soso S; Unger HW; Sawera C; Ome M; Umbers AJ; Ndrewei N; Siba P; Li Wai Suen CS; Vallely A; Wapling J; Ryan C; Mueller I; Rogerson SJ
Sex Transm Infect; 2015 May; 91(3):194-200. PubMed ID: 25313204
[TBL] [Abstract][Full Text] [Related]
15. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery.
Sangkomkamhang US; Lumbiganon P; Prasertcharoensuk W; Laopaiboon M
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD006178. PubMed ID: 25922860
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and Costs of Molecular Screening and Treatment for Bacterial Vaginosis to Prevent Preterm Birth: The AuTop Randomized Clinical Trial.
Bretelle F; Loubière S; Desbriere R; Loundou A; Blanc J; Heckenroth H; Schmitz T; Benachi A; Haddad B; Mauviel F; Danoy X; Mares P; Chenni N; Ménard JP; Cocallemen JF; Slim N; Sénat MV; Chauleur C; Bohec C; Kayem G; Trastour C; Bongain A; Rozenberg P; Serazin V; Fenollar F;
JAMA Pediatr; 2023 Sep; 177(9):894-902. PubMed ID: 37459059
[TBL] [Abstract][Full Text] [Related]
17. Chlamydia trachomatis, Neisseria gonorrhoea, and Trichomonas vaginalis infections among pregnant women and male partners in Dutch midwifery practices: prevalence, risk factors, and perinatal outcomes.
Op de Coul ELM; Peek D; van Weert YWM; Morré SA; Rours I; Hukkelhoven C; de Jonge A; van Benthem B; Pereboom M
Reprod Health; 2021 Jun; 18(1):132. PubMed ID: 34174905
[TBL] [Abstract][Full Text] [Related]
18. Evaluating Chlamydia trachomatis and Neisseria gonorrhoeae screening and treatment among asymptomatic pregnant women to prevent preterm birth and low birthweight in Gaborone, Botswana: A secondary analysis from a non-randomised, cluster-controlled trial.
Wynn A; Mussa A; Ryan R; Babalola CM; Hansman E; Ramontshonyana K; Tamuthiba L; Ndlovu N; Wilson ML; Ramogola-Masire D; Klausner JD; Morroni C
BJOG; 2024 Feb; ():. PubMed ID: 38351649
[TBL] [Abstract][Full Text] [Related]
19. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
Subtil D; Brabant G; Tilloy E; Devos P; Canis F; Fruchart A; Bissinger MC; Dugimont JC; Nolf C; Hacot C; Gautier S; Chantrel J; Jousse M; Desseauve D; Plennevaux JL; Delaeter C; Deghilage S; Personne A; Joyez E; Guinard E; Kipnis E; Faure K; Grandbastien B; Ancel PY; Goffinet F; Dessein R
Lancet; 2018 Nov; 392(10160):2171-2179. PubMed ID: 30322724
[TBL] [Abstract][Full Text] [Related]
20. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy.
Blackwell AL; Thomas PD; Wareham K; Emery SJ
Lancet; 1993 Jul; 342(8865):206-10. PubMed ID: 8100930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
